Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies

P C Simmonds, J N Primrose, J L Colquitt, O J Garden, G J Poston, M Rees, P C Simmonds, J N Primrose, J L Colquitt, O J Garden, G J Poston, M Rees

Abstract

No consensus on the indications for surgical resection of colorectal liver metastases exists. This systematic review has been undertaken to assess the published evidence for its efficacy and safety and to identify prognostic factors. Studies were identified by computerised and hand searches of the literature, scanning references and contacting investigators. The outcome measures were overall survival, disease-free survival, postoperative morbidity and mortality, quality of life and cost effectiveness, and a qualitative summary of the trends across all studies was produced. Only 30 of 529 independent studies met all the eligibility criteria for the review, and data on 30-day mortality and morbidity only were included from a further nine studies. The best available evidence came from prospective case series, but only two studies reported outcomes for all patients undergoing surgery. The remainder reported outcomes for selected groups of patients: those undergoing hepatic resection or those undergoing curative resection. Postoperative mortality rates were generally low (median 2.8%). The majority of studies described only serious postoperative morbidity, the most common being bile leak and associated perihepatic abscess. Approximately 30% of patients remained alive 5 years after resection and around two-thirds of these are disease free. The quality of the majority of published papers was poor and ascertaining the benefits of surgical resection of colorectal hepatic metastases is difficult in the absence of randomised trials. However, it is clear that there is group of patients with liver metastases who may become long-term disease-free survivors following hepatic resection. Such survival is rare in apparently comparable patients who do not have surgical treatment. Further work is needed to more accurately define this group of patients and to determine whether the addition of adjuvant treatments results in improved survival.

References

    1. Abdalla EK, Barnett CC, Doherty D, Curley SA, Vauthey JN (2002) Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. Arch Surg 137: 675–680
    1. Adam R, Akpinar E, Johann M, Kunstlinger F, Majno P, Bismuth H (1997) Place of cryosurgery in the treatment of malignant liver tumors. Ann Surg 225: 38–39
    1. Ambiru S, Miyazaki M, Isono T, Ito H, Nakagawa K, Shimizu H, Kusashio K, Furuya S, Nakajima N (1999a) Hepatic resection for colorectal metastases: analysis of prognostic factors. Dis Colon Rectum 42: 632–639
    1. Ambiru S, Miyazaki M, Ito H, Nakagawa K, Shimizu H, Nakajima N (1999b) Adjuvant regional chemotherapy after hepatic resection for colorectal metastases. Br J Surg 86: 1025–1031
    1. Armstrong JG, Anderson LL, Harrison LB (1994) Treatment of liver metastases from colorectal cancer with radioactive implants. Cancer 73: 1800–1804
    1. Bakalakos EA, Kim JA, Young DC, Martin Jr EW (1998a) Determinants of survival following hepatic resection for metastatic colorectal cancer. World J Surg 22: 399–404
    1. Bakalakos EA, Young DC, Martin Jr EW (1998b) Radioimmunoguided surgery for patients with liver metastases secondary to colorectal cancer. Ann Surg Oncol 5: 590–594
    1. Beckurts KT, Holscher AH, Thorban S, Bollschweiler E, Siewert JR (1997) Significance of lymph node involvement at the hepatic hilum in the resection of colorectal liver metastases. Br J Surg 84: 1081–1084
    1. Bengtsson G, Carlsson G, Hafstrom L, Jonsson PE (1981) Natural history of patients with untreated liver metastases from colorectal cancer. Am J Surg 141: 586–589
    1. Boey J, Choi TK, Wong J, Ong GB (1981) Carcinoma of the colon and rectum with liver involvement. Surg Gynecol Obstet 153: 864–868
    1. Bolton JS, Fuhrman GM (2000) Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma. Ann Surg 231: 743–751
    1. Bradley AL, Chapman WC, Wright JK, Marsh JW, Geevarghese S, Blair KT, Pinson CW (1999) Surgical experience with hepatic colorectal metastasis. Am Surg 65: 560–566
    1. Brand MI, Saclarides TJ, Dobson HD, Millikan KW (2000) Liver resection for colorectal cancer: liver metastases in the aged. Am Surg 66: 412–415
    1. Cady B, Jenkins RL, Steele Jr GD, Lewis WD, Stone MD, McDermott WV, Jessup JM, Bothe A, Lalor P, Lovett EJ, Lavin P, Linehan DC (1998) Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome. Ann Surg 227: 566–571
    1. Cals L, Rixe O, Francois E, Favre R, Merad L, Deplanque G, Laadem A, Juin P, Bereder JM, Bernardini D, Herait P (2004) Dose-finding study of weekly 24-h continuous infusion of 5-fluorouracil associated with alternating oxaliplatin or irinotecan in advanced colorectal cancer patients. Ann Oncol 15: 1018–1024
    1. Cancer Research UK Information Resource Centre (2003) CancerStats. http//:infocancerresearchukorg/cancerstats
    1. Cowley DE (1995) Prostheses for primary total hip replacement. A critical appraisal of the literature. Int J Technol Assess Health Care 11: 770–778
    1. Cunningham D, Humblet Y, Siena S, Khayat D, Bleiberg H, Santoro A, Bets D, Mueser M, Harstrick A, Verslype C, Chau I, Van CE (2004) Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 351: 337–345
    1. de Baere T., Elias D, Ducreux M, Dromain C, Kuach V, Gamal El Din M, Sobotka A, Lasser P, Roche A (1999) Percutaneous radiofrequency ablation of hepatic metastases. Preliminary experience. Gastroenterol Clin Biol 23: 1128–1133
    1. de Gramont A., Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J, Boni C, Cortes-Funes H, Cervantes A, Freyer G, Papamichael D, Le Bail N., Louvet C, Hendler D, de Braud F., Wilson C, Morvan F, Bonetti A (2000) Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18: 2938–2947
    1. DeMatteo RP, Palese C, Jarnagin WR, Sun RL, Blumgart LH, Fong Y (2000) Anatomic segmental hepatic resection is superior to wedge resection as an oncologic operation for colorectal liver metastases. J Gastrointest Surg 4: 178–184
    1. Doci R, Bignami P, Montalto F, Gennari L (1995) Prognostic factors for survival and disease-free survival in hepatic metastases from colorectal cancer treated by resection. Tumori 81: 143–146
    1. Donato N, Dario C, Giovanni S, Virgilio B, Paolo DP, Roberto L, Gianfranco P, Mario L, Daniela P, Angelo T (1994) Retrospective study on adjuvant chemotherapy after surgical resection of colorectal cancer metastatic to the liver. Eur J Surg Oncol 20: 454–460
    1. Donovan TB (1995) Interstitial treatment of colorectal metastases to the liver. Appl Radiol 24: 41–44
    1. Douillard JY, Cunningham D, Roth AD, Navarro M, James RD, Karasek P, Jandik P, Iveson T, Carmichael J, Alakl M, Gruia G, Awad L, Rougier P (2000) Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 355: 1041–1047
    1. Downs SH, Black N (1998) The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 52: 377–384
    1. Fegiz G, Ramacciato G, Gennari L, Doci R, Pezzuoli G, Leggeri A, Peracchia A, Montorsi W, D'Angelo F, Aurello P (1991) Hepatic resections for colorectal metastases: the Italian multicenter experience. J Surg Oncol Suppl 2: 144–154
    1. Fernandez-Trigo V, Shamsa F, Sugarbaker PH (1995) Repeat liver resections from colorectal metastasis. Repeat Hepatic Metastases Registry. Surgery 117: 296–304
    1. Figueras J, Valls C, Rafecas A, Fabregat J, Ramos E, Jaurrieta E (2001) Resection rate and effect of postoperative chemotherapy on survival after surgery for colorectal liver metastases. Br J Surg 88: 980–985
    1. Finan PJ, Marshall RJ, Cooper EH, Giles GR (1985) Factors affecting survival in patients presenting with synchronous hepatic metastases from colorectal cancer: a clinical and computer analysis. Br J Surg 72: 373–377
    1. Fong Y, Blumgart LH, Fortner JG, Brennan MF (1995) Pancreatic or liver resection for malignancy is safe and effective for the elderly. Ann Surg 222: 426–434
    1. Fong Y, Cohen AM, Fortner JG, Enker WE, Turnbull AD, Coit DG, Marrero AM, Prasad M, Blumgart LH, Brennan MF (1997) Liver resection for colorectal metastases. J Clin Oncol 15: 938–946
    1. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230: 309–318
    1. Fong Y, Salo J (1999) Surgical therapy of hepatic colorectal metastasis. Semin Oncol 26: 514–523
    1. Fuhrman GM, Curley SA, Hohn DC, Roh MS (1995) Improved survival after resection of colorectal liver metastases. Ann Surg Oncol 2: 537–541
    1. Gayowski TJ, Iwatsuki S, Madariaga JR, Selby R, Todo S, Irish W, Starzl TE (1994) Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery 116: 703–710
    1. Geoghegan JG, Scheele J (1999) Treatment of colorectal liver metastases. Br J Surg 86: 158–169
    1. Giacchetti S, Itzhaki M, Gruia G, Adam R, Zidani R, Kunstlinger F, Brienza S, Alafaci E, Bertheault-Cvitkovic F, Jasmin C, Reynes M, Bismuth H, Misset JL, Levi F (1999) Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol 10: 663–669
    1. Goldberg RM, Fleming TR, Tangen CM, Moertel CG, Macdonald JS, Haller DG, Laurie JA (1998) Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group. Ann Intern Med 129: 27–35
    1. Goldberg RM, Sargent DJ, Morton RF, Fuchs CS, Ramanathan RK, Williamson SK, Findlay BP, Pitot HC, Alberts SR (2004) A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 22: 23–30
    1. Gorog D, Toth A, Weltner J (1997) Prognosis of untreated liver metastasis from rectal cancer. Acta Chir Hung 36: 106–107
    1. Goslin R, Steele Jr G, Zamcheck N, Mayer R, MacIntyre J (1982) Factors influencing survival in patients with hepatic metastases from adenocarcinoma of the colon or rectum. Dis Colon Rectum 25: 749–754
    1. Grothey A, Sargent D, Goldberg RM, Schmoll HJ (2004) Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment. J Clin Oncol 22: 1209–1214
    1. Harmon KE, Ryan Jr JA, Biehl TR, Lee FT (1999) Benefits and safety of hepatic resection for colorectal metastases. Am J Surg 177: 402–404
    1. Harms J, Obst T, Thorban S, Busch R, Fink U, Heidecke CD, Roder JD, Siewert JR (1999) The role of surgery in the treatment of liver metastases for colorectal cancer patients. Hepatogastroenterology 46: 2321–2328
    1. Hohenberger P, Schlag P, Schwarz V, Herfarth C (1990) Tumor recurrence and options for further treatment after resection of liver metastases in patients with colorectal cancer. J Surg Oncol 44: 245–251
    1. Hohenberger P, Schlag PM, Gerneth T, Herfarth C (1994) Pre- and postoperative carcinoembryonic antigen determinations in hepatic resection for colorectal metastases. Predictive value and implications for adjuvant treatment based on multivariate analysis. Ann Surg 219: 135–143
    1. Hugh TJ, Kinsella AR, Poston GJ (1997a) Management strategies for colorectal liver metastases – Part I. Surg Oncol 6: 19–30
    1. Hugh TJ, Kinsella AR, Poston GJ (1997b) Management strategies for colorectal liver metastases – Part II. Surg Oncol 6: 31–48
    1. Hughes K, Scheele J, Sugarbaker PH (1989) Surgery for colorectal cancer metastatic to the liver. Optimizing the results of treatment. Surg Clin North Am 69: 339–359
    1. Hughes KS, Rosenstein RB, Songhorabodi S, Adson MA, Ilstrup DM, Fortner JG, Maclean BJ, Foster JH, Daly JM, Fitzherbert D (1988) Resection of the liver for colorectal carcinoma metastases. A multi-institutional study of long-term survivors. Dis Colon Rectum 31: 1–4
    1. Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, Berlin J, Baron A, Griffing S, Holmgren E, Ferrara N, Fyfe G, Rogers B, Ross R, Kabbinavar F (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350: 2335–2342
    1. Iwatsuki S, Dvorchik I, Madariaga JR, Marsh JW, Dodson F, Bonham AC, Geller DA, Gayowski TJ, Fung JJ, Starzl TE (1999) Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg 189: 291–299
    1. Jamison RL, Donohue JH, Nagorney DM, Rosen CB, Harmsen WS, Ilstrup DM (1996) Hepatic resection for metastatic colorectal carcinoma results in the cure of some patients. Gastroenterology 110: A1394
    1. Jamison RL, Donohue JH, Nagorney DM, Rosen CB, Harmsen WS, Ilstrup DM (1997) Hepatic resection for metastatic colorectal cancer results in cure for some patients. Arch Surg 132: 505–510
    1. Jeffery GM, Hickey BE, Hider P (2002) Follow-up strategies for patients treated for non-metastatic colorectal cancer. The Cochrane Database of Systematic Reviews 2002, Issue 1. Art. No.: CD002200. DOI: 10.1002/14651858.CD002200
    1. Jenkins LT, Millikan KW, Bines SD, Staren ED, Doolas A (1997) Hepatic resection for metastatic colorectal cancer. Am Surg 63: 605–610
    1. Kemeny MM, Adak S, Gray B, Macdonald JS, Smith T, Lipsitz S, Sigurdson ER, O'Dwyer PJ, Benson III AB (2002) Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy – an intergroup study. J Clin Oncol 20: 1499–1505
    1. Kemeny MM, Adak S, Lipsitz S, Gray B, MacDonald J, Benson II AB (1999a) Results of the Intergroup [Eastern Cooperative Oncology Group (ECOG) and Southwest Oncology Group (SWOG)] prospective randomized study of surgery alone versus continuous hepatic artery infusion of fudr and continuous systemic infusion of 5fu after hepatic resection for colorectal liver metastases. Proc Am Soc Clin Onc 18 (Meeting abstract 1012)
    1. Kemeny N, Cohen A, Huang Y, Shi W, Blumgart L, Turnbull A, Sullivan D, Stockman J, Fong Y (1999b) Randomized study of hepatic arterial infusion (HAI) and systemic chemotherapy (SYS) versus sys alone as adjuvant therapy after resection of hepatic metastases from colorectal cancer. Proc Am Soc Clin Onc 18 (abstract 1011)
    1. Kemeny N, Huang Y, Cohen AM, Shi W, Conti JA, Brennan MF, Bertino JR, Turnbull AD, Sullivan D, Stockman J, Blumgart LH, Fong Y (1999c) Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 341: 2039–2048
    1. Lahr CJ, Soong SJ, Cloud G, Smith JW, Urist MM, Balch CM (1983) A multifactorial analysis of prognostic factors in patients with liver metastases from colorectal carcinoma. J Clin Oncol 1: 720–726
    1. Lange JF, Leese T, Castaing D, Bismuth H (1989) Repeat hepatectomy for recurrent malignant tumors of the liver. Surg Gynecol Obstet 169: 119–126
    1. Leslie KA, Rossi R, Hughes K, Tsao J (1995) Survival expectancy of patients alive 5 years after hepatic resection for metastatic colon carcinoma: report from the registry of hepatic metastases. Proc Am Soc Clin Onc 14 (abstract 477)
    1. Lorenz M, Muller HH, Schramm H, Gassel HJ, Rau HG, Ridwelski K, Hauss J, Stieger R, Jauch KW, Bechstein WO, Encke A (1998) Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen). Ann Surg 228: 756–762
    1. Lorenz M, Staib-Sebler E, Koch B, Gog C, Waldeyer M, Encke A (1997) The value of postoperative hepatic arterial infusion following curative liver resection. Anticancer Res 17: 3825–3833
    1. Minagawa M, Makuuchi M, Torzilli G, Takayama T, Kawasaki S, Kosuge T, Yamamoto J, Imamura H (2000) Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg 231: 487–499
    1. Minagawa M, Takayama T, Makuuchi M (1999) Late results justify resection for multiple and bilateralhepatic metastasis from colorectal cancer. Gastroenterology 116: G2043
    1. Minton JP, Abou-Issa H (1990) Resection of hepatic metastases of colorectal carcinoma. Ohio Med 86: 191
    1. Moroz P, Salama PR, Gray BN (2002) Resecting large numbers of hepatic colorectal metastases. ANZ J Surg 72: 5–10
    1. Nadig DE, Wade TP, Fairchild RB, Virgo KS, Johnson FE (1997) Major hepatic resection. Indications and results in a national hospital system from 1988 to 1992. Arch Surg 132: 115–119
    1. Nordlinger B, Jaeck D, Guiget M, Vaillant JC, Balladur P, Schaal JC (1992) Surgical resection of hepatic metastases: multicentric retrospective study by the French Association of Surgery. In Treatment of Hepatic Metastases of Colorectal Cancer, Nordlinger B, Jaeck D (eds), pp 129–161. Paris: Springer-Verlag
    1. Nordlinger B, Sorbye H, Debois M, Praet M, Glimelius B, Poston GJ, Schlag PM, Walpole ET, Bechstein W, Gruenberger T (2005) Feasibility and risks of pre-operative chemotherapy (CT) with Folfox 4 and surgery for resectable colorectal cancer liver metastases (LM). Interim results of the EORTC Intergroup randomized phase III study 40983. Proc Am Soc Clin Oncol 23 (abstract 3528)
    1. Nordlinger B, Vaillant JC, Guiguet M, Balladur P, Paris F, Bachellier P, Jaeck D (1994) Survival benefit of repeat liver resections for recurrent colorectal metastases: 143 cases. Association Francaise de Chirurgie. J Clin Oncol 12: 1491–1496
    1. Ohlsson B, Stenram U, Tranberg KG (1998) Resection of colorectal liver metastases: 25-year experience. World J Surg 22: 268–276
    1. Okano K, Yamamoto J, Kosuge T, Yamamoto S, Sakamoto M, Nakanishi Y, Hirohashi S (2000) Fibrous pseudocapsule of metastatic liver tumors from colorectal carcinoma. Clinicopathologic study of 152 first resection cases. Cancer 89: 267–275
    1. Pawlik TM, Scoggins CR, Zorzi D, Abdalla EK, Andres A, Eng C, Curley SA, Loyer EM, Muratore A, Mentha G, Capussotti L, Vauthey JN (2005) Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 241: 715–722 (discussion)
    1. Poston GJ, Adam R, Alberts S, Curley S, Figueras J, Haller D, Kunstlinger F, Mentha G, Nordlinger B, Patt Y, Primrose J, Roh M, Rougier P, Ruers T, Schmoll HJ, Valls C, Vauthey NJ, Cornelis M, Kahan JP (2005) OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer. J Clin Oncol 23: 7125–7134
    1. Primrose JN (2002) Treatment of colorectal metastases: surgery, cryotherapy, or radiofrequency ablation. Gut 50: 1–5
    1. Rees M, Plant G, Bygrave S (1997) Late results justify resection for multiple hepatic metastases from colorectal cancer. Br J Surg 84: 1136–1140
    1. Riesener KP, Winkeltau G, Kasperk R, Cheng L, Schumpelick V (1998) Adjuvant regional arterial port chemotherapy after resection of colorectal liver metastases. Chirurg 69: 741–746
    1. Rosen CB, Nagorney DM, Taswell HF, Helgeson SL, Ilstrup DM, van Heerden JA, Adson MA (1992) Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg 216: 493–504
    1. Rougier P, Milan C, Lazorthes F, Fourtanier G, Partensky C, Baumel H, Faivre J (1995) Prospective study of prognostic factors in patients with unresected hepatic metastases from colorectal cancer. Fondation Francaise de Cancerologie Digestive. Br J Surg 82: 1397–1400
    1. Saltz LB, Cox JV, Blanke C, Rosen LS, Fehrenbacher L, Moore MJ, Maroun JA, Ackland SP, Locker PK, Pirotta N, Elfring GL, Miller LL (2000) Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 343: 905–914
    1. Saltz LB, Meropol NJ, Loehrer Sr PJ, Needle MN, Kopit J, Mayer RJ (2004) Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor. J Clin Oncol 22: 1201–1208
    1. Savage AP, Malt RA (1992) Survival after hepatic resection for malignant tumours. Br J Surg 79: 1095–1101
    1. Scheele J, Altendorf-Hofmann A, Stangl R, Schmidt K (1996) Surgical resection of colorectal liver metastases: Gold standard for solitary and radically resectable lesions. Swiss Surg, Suppl 4: 4–17
    1. Scheele J, Stang R, Altendorf-Hofmann A, Paul M (1995) Resection of colorectal liver metastases. World J Surg 19: 59–71
    1. Scheele J, Stangl R, Altendorf-Hofmann A (1990) Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg 77: 1241–1246
    1. Scheele J, Stangl R, Altendorf-Hofmann A, Gall FP (1991) Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 110: 13–29
    1. Seymour MT, Stenning SP, Cassidy J (1997) Attitudes and practice in the management of metastatic colorectal cancer in Britain. Colorectal Cancer Working Party of the UK Medical Research Council. Clin Oncol (R Coll Radiol) 9: 248–251
    1. Simmonds PC (2000) Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group. BMJ 321: 531–535
    1. Stangl R, Altendorf-Hofmann A, Charnley RM, Scheele J (1994) Factors influencing the natural history of colorectal liver metastases. Lancet 343: 1405–1410
    1. Steele Jr G, Bleday R, Mayer RJ, Lindblad A, Petrelli N, Weaver D (1991) A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Gastrointestinal Tumor Study Group Protocol 6584. J Clin Oncol 9: 1105–1112
    1. Steele Jr G, Mayer R, Lindblad AA (1995) A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: follow-up report. J Hepatic Biliary Pancreatic Surg 2: 122–125
    1. Sugihara K, Hojo K, Moriya Y, Yamasaki S, Kosuge T, Takayama T (1993) Pattern of recurrence after hepatic resection for colorectal metastases. Br J Surg 80: 1032–1035
    1. Taylor M, Forster J, Langer B, Taylor BR, Greig PD, Mahut C (1997) A study of prognostic factors for hepatic resection for colorectal metastases. Am J Surg 173: 467–471
    1. Tournigand C, Andre T, Achille E, Lledo G, Flesh M, Mery-Mignard D, Quinaux E, Couteau C, Buyse M, Ganem G, Landi B, Colin P, Louvet C, de GA (2004) FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 22: 229–237
    1. van Ooijen B, Wiggers T, Meijer S, van der Heijde MN, Slooff MJ, van de Velde CJ, Obertop H, Gouma DJ, Bruggink ED, Lange JF (1992) Hepatic resections for colorectal metastases in The Netherlands. A multiinstitutional 10-year study. Cancer 70: 28–34
    1. Wade TP, Virgo KS, Li MJ, Callander PW, Longo WE, Johnson FE (1996) Outcomes after detection of metastatic carcinoma of the colon and rectum in a national hospital system. J Am Coll Surg 182: 353–361
    1. Wagner JS, Adson MA, van Heerden JA, Adson MH, Ilstrup DM (1984) The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann Surg 199: 502–508
    1. Weiss L, Grundmann E, Torhorst J, Hartveit F, Moberg I, Eder M, Fenoglio-Preiser CM, Napier J, Horne CH, Lopez MJ (1986) Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J Pathol 150: 195–203
    1. Wood CB, Gillis CR, Blumgart LH (1976) A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol 2: 285–288

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi